Genitourinary cancer includes bladder, kidney, ovarian, prostate and several other cancers.
We are currently investigating experimental medications for bladder, prostate and renal cell (kidney) cancer. Answer a few questions below to see if there are clinical trials that might be right for you.
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer.View Trial Details
Get updates on Genitourinary cancer clinical trials